{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:29:52Z","timestamp":1794652192871,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>The concept of oncocytoid renal cell carcinoma in patients who have survived neuroblastoma as a distinct biologic entity has been controversial since its original description in 1999. This is in part because similar oncocytoid renal cell carcinomas have been described in association with other pediatric cancers, and also because other renal cell carcinoma subtypes (such as MiT family translocation renal cell carcinoma) have been described in children who have survived neuroblastoma. We identified an index case of a child who survived medulloblastoma and developed multifocal bilateral oncocytoid renal cell carcinomas with morphology and immunophenotype compatible with eosinophilic solid and cystic renal cell carcinoma (ESC RCC) and demonstrated that both neoplasms harbored distinctive mutations in the <jats:italic toggle=\"yes\">TSC1\/TSC2<\/jats:italic> genes. Remarkably, the child\u2019s remaining bilateral multifocal renal neoplasms completely responded to MTOR inhibitor therapy without need for further surgery. To confirm our hypothesis that oncocytoid renal cell carcinomas after childhood cancer represent ESC RCC, we obtained formalin-fixed paraffin-embedded tissue blocks from 2 previously published cases of oncocytoid renal cell carcinoma after neuroblastoma, confirmed that the morphology and immunophenotype was consistent with ESC RCC, and demonstrated that both cases harbored somatic <jats:italic toggle=\"yes\">TSC<\/jats:italic> gene mutations. Both expressed markers previously associated with neoplasms harboring TSC gene mutations, glycoprotein nonmetastatic B, and cathepsin K. Of note, one of these patients had 2 ESC RCC which harbored distinctive <jats:italic toggle=\"yes\">TSC2<\/jats:italic> mutations, while the background kidney of the other patient had multiple small cysts lined by similar oncocytoid cells which showed loss of TSC2 protein. We then reviewed 3 of 4 cases from the original 1999 report of oncocytoid renal cell carcinomas after neuroblastoma, found that all 3 demonstrated morphology (including basophilic cytoplasmic stippling) that is characteristic of ESC RCC, showed that all 3 overexpressed glycoprotein nonmetastatic B, and showed that both cases with adequate material demonstrated loss of TSC2 protein and expressed cytokeratin 20 and cathepsin K by immunohistochemistry. In summary, \u201concocytoid renal cell carcinomas after neuroblastoma\u201d represent ESC RCC which are often multifocal in patients who have survived childhood cancer, likely representing an incompletely characterized tumor predisposition syndrome. MTOR-targeted therapy represents an effective therapeutic option for such patients to preserve functional nephrons.<\/jats:p>","DOI":"10.1097\/pas.0000000000002101","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T10:00:09Z","timestamp":1690797609000},"page":"1335-1348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["\u201cOncocytoid Renal Cell Carcinomas After Neuroblastoma\u201d Represent TSC-mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas"],"prefix":"10.1097","volume":"47","author":[{"given":"Pedram","family":"Argani","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Urology"},{"name":"Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Urology"},{"name":"Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Baraban","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Urology"},{"name":"Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Lotan","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Urology"},{"name":"Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Pawel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital Los Angeles and Keck School of Medicine of the University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[{"name":"Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Pathology and Michigan Center for Translational Pathology (MCTP), University of Michigan School of Medicine, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Falzarano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Pallavajjalla","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Urology"},{"name":"Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tseh","family":"Lin","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Urology"},{"name":"Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Patel","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawhar","family":"Rawwas","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Children\u2019s Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Bendel","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Children\u2019s Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gagan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen N.","family":"Palsgrove","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-199907000-00004","article-title":"Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity","volume":"23","author":"Medeiros","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.2005.04.4693","article-title":"Translocation carcinomas of the kidney after chemotherapy in childhood","volume":"24","author":"Argani","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"178.e13","DOI":"10.1016\/j.urology.2007.03.055","article-title":"Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma","volume":"70","author":"Dhall","year":"2007","journal-title":"Urology"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma. Clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/PAS.0000000000000632","article-title":"Renal cell carcinoma occurring in patients with prior neuroblastoma: a heterogenous group of neoplasms","volume":"40","author":"Falzarano","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/leu.2016.63","article-title":"Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation","volume":"30","author":"Gondek","year":"2016","journal-title":"Leukemia"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/PAS.0000000000001467","article-title":"Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations","volume":"44","author":"Argani","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000203","article-title":"t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and translocation-driven renal tumors","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0387-7604(02)00017-7","article-title":"Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex","volume":"24","author":"Yamamoto","year":"2002","journal-title":"Brain Dev"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.eplepsyres.2012.07.007","article-title":"Central TSC2 missense mutations are associated with a reduced risk of infantile spasms","volume":"103","author":"van Eeghen","year":"2013","journal-title":"Epilepsy Res"},{"key":"R19-20250608","first-page":"223","article-title":"Analysis of gene mutation in patients with tuberous sclerosis complex with polymerase chain reaction-single strand conformation polymorphism","volume":"41","author":"Feng","year":"2003","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.rbmo.2012.07.003","article-title":"PGD for germline mosaicism","volume":"25","author":"Altarescu","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12881-018-0686-6","article-title":"Identification of a novel TSC2 c.3610G > A, p.G1204R mutation contribute to aberrant splicing in a patient with classical tuberous sclerosis complex: a case report","volume":"19","author":"Zhang","year":"2018","journal-title":"BMC Med Genet"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/ajrccm.164.4.2011025","article-title":"Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis","volume":"15","author":"Franz","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.22202","article-title":"Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex","volume":"34","author":"Hoogeveen-Westerveld","year":"2013","journal-title":"Hum Mutat"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/hmg\/10.25.2899","article-title":"Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin","volume":"1","author":"Hodges","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/ejhg.2015.47","article-title":"Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2","volume":"23","author":"Kwiatkowski","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin-K in neoplasms harbouring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li","year":"2018","journal-title":"Histopathology"},{"key":"R29-20250608","first-page":"1","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of tsc patients with no mutation identified by conventional testing","volume":"5","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00439-010-0801-z","article-title":"Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex","volume":"127","author":"Qin","year":"2010","journal-title":"Hum Genet"},{"key":"R31-20250608","first-page":"1","article-title":"Diagnosis of mosaic tuberous sclerosis complex using next-generation sequencing of subtle or unusual cutaneous findings","volume":"9","author":"Treichel","year":"2023","journal-title":"JID Innov"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2016.01.028","article-title":"Acquired multiple cysts of the kidney in neuroblastoma survivors","volume":"68","author":"Moodalbail","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7 positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13457","article-title":"Eosinophilic solid and cystic renal cell carcinomas have metastatic potential","volume":"72","author":"McKenney","year":"2018","journal-title":"Histopathology"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"1122390","DOI":"10.3389\/fped.2023.1122390","article-title":"Nephron-sparing surgery for Wilms tumor","volume":"11","author":"Murphy","year":"2023","journal-title":"Front Pediatr"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/PAS.0000000000001940","article-title":"Xanthomatous giant cell renal cell carcinoma: another morphologic form of TSC-associated renal cell carcinoma","volume":"46","author":"Argani","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0000000000001955","article-title":"TSC\/MTOR-associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum : a targeted next-generation sequencing and gene expression profiling study","volume":"46","author":"Xia","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","article-title":"Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma","volume":"22","author":"Kwiatkowski","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:01:58Z","timestamp":1749412918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002101"}},"subtitle":["Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications"],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002101","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}